Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 133

1.

Cell-cell adhesion: linking Wnt/β-catenin signaling with partial EMT and stemness traits in tumorigenesis.

Basu S, Cheriyamundath S, Ben-Ze'ev A.

F1000Res. 2018 Sep 18;7. pii: F1000 Faculty Rev-1488. doi: 10.12688/f1000research.15782.1. eCollection 2018. Review.

2.

The intestinal stem cell regulating gene ASCL2 is required for L1-mediated colon cancer progression.

Basu S, Gavert N, Brabletz T, Ben-Ze'ev A.

Cancer Lett. 2018 Jun 28;424:9-18. doi: 10.1016/j.canlet.2018.03.022. Epub 2018 Mar 15.

PMID:
29551399
3.

A point mutation in the extracellular domain of L1 blocks its capacity to confer metastasis in colon cancer cells via CD10.

Haase G, Gavert N, Brabletz T, Ben-Ze'ev A.

Oncogene. 2017 Mar;36(11):1597-1606. doi: 10.1038/onc.2016.329. Epub 2016 Sep 19.

PMID:
27641335
4.

The Wnt Target Gene L1 in Colon Cancer Invasion and Metastasis.

Haase G, Gavert N, Brabletz T, Ben-Ze'ev A.

Cancers (Basel). 2016 May 11;8(5). pii: E48. doi: 10.3390/cancers8050048. Review.

5.

Wnt signaling in cancer stem cells and colon cancer metastasis.

Basu S, Haase G, Ben-Ze'ev A.

F1000Res. 2016 Apr 19;5. pii: F1000 Faculty Rev-699. doi: 10.12688/f1000research.7579.1. eCollection 2016. Review.

6.

The unique role of the agent within the romantic group.

Ben-Ze'ev A, Krebs A.

Behav Brain Sci. 2016 Jan;39:e140. doi: 10.1017/S0140525X15001284.

PMID:
28355776
7.

Retraction notice to "Regulation of p53: Intricate loops and delicate balances" [Biochem. Pharmacol. 64 (2002) 865-871].

Oren M, Damalas A, Gottlieb T, Michael D, Taplick J, Martinez Leal JF, Maya R, Moas M, Seger R, Taya Y, Ben-Ze'ev A.

Biochem Pharmacol. 2015 Aug 15;96(4):369. doi: 10.1016/j.bcp.2015.07.001. No abstract available.

PMID:
26465018
8.

Clusterin, a gene enriched in intestinal stem cells, is required for L1-mediated colon cancer metastasis.

Shapiro B, Tocci P, Haase G, Gavert N, Ben-Ze'ev A.

Oncotarget. 2015 Oct 27;6(33):34389-401. doi: 10.18632/oncotarget.5360.

9.

Induction of the intestinal stem cell signature gene SMOC-2 is required for L1-mediated colon cancer progression.

Shvab A, Haase G, Ben-Shmuel A, Gavert N, Brabletz T, Dedhar S, Ben-Ze'ev A.

Oncogene. 2016 Feb 4;35(5):549-57. doi: 10.1038/onc.2015.127. Epub 2015 Apr 27.

PMID:
25915847
10.

The modern search for the Holy Grail: is neuroscience a solution?

Naor N, Ben-Ze'ev A, Okon-Singer H.

Front Hum Neurosci. 2014 Jun 4;8:388. doi: 10.3389/fnhum.2014.00388. eCollection 2014. Erratum in: Front Hum Neurosci. 2014;8:515.

11.

c-Kit is suppressed in human colon cancer tissue and contributes to L1-mediated metastasis.

Gavert N, Shvab A, Sheffer M, Ben-Shmuel A, Haase G, Bakos E, Domany E, Ben-Ze'ev A.

Cancer Res. 2013 Sep 15;73(18):5754-63. doi: 10.1158/0008-5472.CAN-13-0576. Epub 2013 Sep 5.

12.

Global analysis of L1-transcriptomes identified IGFBP-2 as a target of ezrin and NF-κB signaling that promotes colon cancer progression.

Ben-Shmuel A, Shvab A, Gavert N, Brabletz T, Ben-Ze'ev A.

Oncogene. 2013 Jul 4;32(27):3220-30. doi: 10.1038/onc.2012.340. Epub 2012 Aug 6.

PMID:
22869145
13.

Coordinating changes in cell adhesion and phenotype during EMT-like processes in cancer.

Gavert N, Ben-Ze'ev A.

F1000 Biol Rep. 2010 Dec 8;2:86. doi: 10.3410/B2-86.

14.

L1-mediated colon cancer cell metastasis does not require changes in EMT and cancer stem cell markers.

Gavert N, Vivanti A, Hazin J, Brabletz T, Ben-Ze'ev A.

Mol Cancer Res. 2011 Jan;9(1):14-24. doi: 10.1158/1541-7786.MCR-10-0406. Epub 2010 Dec 1.

15.

Nuclear factor-kappaB signaling and ezrin are essential for L1-mediated metastasis of colon cancer cells.

Gavert N, Ben-Shmuel A, Lemmon V, Brabletz T, Ben-Ze'ev A.

J Cell Sci. 2010 Jun 15;123(Pt 12):2135-43. doi: 10.1242/jcs.069542. Epub 2010 May 25.

16.

The envious brain: the neural basis of social comparison.

Dvash J, Gilam G, Ben-Ze'ev A, Hendler T, Shamay-Tsoory SG.

Hum Brain Mapp. 2010 Nov;31(11):1741-50. doi: 10.1002/hbm.20972.

PMID:
20205244
17.

The cell adhesion nectin-like molecules (Necl) 1 and 4 suppress the growth and tumorigenic ability of colon cancer cells.

Raveh S, Gavert N, Spiegel I, Ben-Ze'ev A.

J Cell Biochem. 2009 Sep 1;108(1):326-36. doi: 10.1002/jcb.22258.

PMID:
19565570
18.

L1 cell adhesion molecule (L1CAM) in invasive tumors.

Raveh S, Gavert N, Ben-Ze'ev A.

Cancer Lett. 2009 Sep 18;282(2):137-45. doi: 10.1016/j.canlet.2008.12.021. Epub 2009 Jan 13. Review.

PMID:
19144458
19.

L1-CAM in cancerous tissues.

Gavert N, Ben-Shmuel A, Raveh S, Ben-Ze'ev A.

Expert Opin Biol Ther. 2008 Nov;8(11):1749-57. doi: 10.1517/14712598.8.11.1749 . Review.

PMID:
18847309
20.

Epithelial-mesenchymal transition and the invasive potential of tumors.

Gavert N, Ben-Ze'ev A.

Trends Mol Med. 2008 May;14(5):199-209. doi: 10.1016/j.molmed.2008.03.004. Epub 2008 Apr 10.

PMID:
18406208
21.

beta-Catenin signaling in biological control and cancer.

Gavert N, Ben-Ze'ev A.

J Cell Biochem. 2007 Nov 1;102(4):820-8. Review.

PMID:
17854061
22.

Expression of L1-CAM and ADAM10 in human colon cancer cells induces metastasis.

Gavert N, Sheffer M, Raveh S, Spaderna S, Shtutman M, Brabletz T, Barany F, Paty P, Notterman D, Domany E, Ben-Ze'ev A.

Cancer Res. 2007 Aug 15;67(16):7703-12.

23.

Fascin, a novel target of beta-catenin-TCF signaling, is expressed at the invasive front of human colon cancer.

Vignjevic D, Schoumacher M, Gavert N, Janssen KP, Jih G, Laé M, Louvard D, Ben-Ze'ev A, Robine S.

Cancer Res. 2007 Jul 15;67(14):6844-53.

24.

Targeting the active beta-catenin pathway to treat cancer cells.

Dvory-Sobol H, Sagiv E, Kazanov D, Ben-Ze'ev A, Arber N.

Mol Cancer Ther. 2006 Nov;5(11):2861-71.

25.

The shed ectodomain of Nr-CAM stimulates cell proliferation and motility, and confers cell transformation.

Conacci-Sorrell M, Kaplan A, Raveh S, Gavert N, Sakurai T, Ben-Ze'ev A.

Cancer Res. 2005 Dec 15;65(24):11605-12.

26.

Prototypical type I E-cadherin and type II cadherin-7 mediate very distinct adhesiveness through their extracellular domains.

Chu YS, Eder O, Thomas WA, Simcha I, Pincet F, Ben-Ze'ev A, Perez E, Thiery JP, Dufour S.

J Biol Chem. 2006 Feb 3;281(5):2901-10. Epub 2005 Oct 26.

27.

L1, a novel target of beta-catenin signaling, transforms cells and is expressed at the invasive front of colon cancers.

Gavert N, Conacci-Sorrell M, Gast D, Schneider A, Altevogt P, Brabletz T, Ben-Ze'ev A.

J Cell Biol. 2005 Feb 14;168(4):633-42.

28.

Targeted activation of beta-catenin signaling in basal mammary epithelial cells affects mammary development and leads to hyperplasia.

Teulière J, Faraldo MM, Deugnier MA, Shtutman M, Ben-Ze'ev A, Thiery JP, Glukhova MA.

Development. 2005 Jan;132(2):267-77. Epub 2004 Dec 8.

29.

Novel expression of N-cadherin elicits in vitro bladder cell invasion via the Akt signaling pathway.

Rieger-Christ KM, Lee P, Zagha R, Kosakowski M, Moinzadeh A, Stoffel J, Ben-Ze'ev A, Libertino JA, Summerhayes IC.

Oncogene. 2004 Jun 10;23(27):4745-53.

PMID:
15122336
30.
31.

Autoregulation of E-cadherin expression by cadherin-cadherin interactions: the roles of beta-catenin signaling, Slug, and MAPK.

Conacci-Sorrell M, Simcha I, Ben-Yedidia T, Blechman J, Savagner P, Ben-Ze'ev A.

J Cell Biol. 2003 Nov 24;163(4):847-57. Epub 2003 Nov 17.

32.

SKI activates Wnt/beta-catenin signaling in human melanoma.

Chen D, Xu W, Bales E, Colmenares C, Conacci-Sorrell M, Ishii S, Stavnezer E, Campisi J, Fisher DE, Ben-Ze'ev A, Medrano EE.

Cancer Res. 2003 Oct 15;63(20):6626-34.

33.

IKKalpha regulates mitogenic signaling through transcriptional induction of cyclin D1 via Tcf.

Albanese C, Wu K, D'Amico M, Jarrett C, Joyce D, Hughes J, Hulit J, Sakamaki T, Fu M, Ben-Ze'ev A, Bromberg JF, Lamberti C, Verma U, Gaynor RB, Byers SW, Pestell RG.

Mol Biol Cell. 2003 Feb;14(2):585-99.

34.

Nuclear localization of beta-catenin and plakoglobin in primary and metastatic human colonic carcinomas, colonic adenomas, and normal colon.

Lifschitz-Mercer B, Amitai R, Maymon BB, Shechtman L, Czernobilsky B, Leider-Trejo L, Ben-Ze'ev A, Geiger B.

Int J Surg Pathol. 2001 Oct;9(4):273-9.

PMID:
12574842
35.

Regulation of p53: intricate loops and delicate balances.

Oren M, Damalas A, Gottlieb T, Michael D, Taplick J, Leal JF, Maya R, Moas M, Seger R, Taya Y, Ben-Ze'Ev A.

Ann N Y Acad Sci. 2002 Nov;973:374-83.

PMID:
12485897
36.

PML is a target gene of beta-catenin and plakoglobin, and coactivates beta-catenin-mediated transcription.

Shtutman M, Zhurinsky J, Oren M, Levina E, Ben-Ze'ev A.

Cancer Res. 2002 Oct 15;62(20):5947-54.

37.

Regulation of p53: intricate loops and delicate balances.

Oren M, Damalas A, Gottlieb T, Michael D, Taplick J, Leal JF, Maya R, Moas M, Seger R, Taya Y, Ben-Ze'ev A.

Biochem Pharmacol. 2002 Sep;64(5-6):865-71. Retraction in: Oren M, Damalas A, Gottlieb T, Michael D, Taplick J, Martinez Leal JF, Maya R, Moas M, Seger R, Taya Y, Ben-Ze'ev A. Biochem Pharmacol. 2015 Aug 15;96(4):369.

PMID:
12213580
38.

Nr-CAM is a target gene of the beta-catenin/LEF-1 pathway in melanoma and colon cancer and its expression enhances motility and confers tumorigenesis.

Conacci-Sorrell ME, Ben-Yedidia T, Shtutman M, Feinstein E, Einat P, Ben-Ze'ev A.

Genes Dev. 2002 Aug 15;16(16):2058-72.

39.

Regulation of S33/S37 phosphorylated beta-catenin in normal and transformed cells.

Sadot E, Conacci-Sorrell M, Zhurinsky J, Shnizer D, Lando Z, Zharhary D, Kam Z, Ben-Ze'ev A, Geiger B.

J Cell Sci. 2002 Jul 1;115(Pt 13):2771-80.

40.

The cadherin-catenin adhesion system in signaling and cancer.

Conacci-Sorrell M, Zhurinsky J, Ben-Ze'ev A.

J Clin Invest. 2002 Apr;109(8):987-91. Review. No abstract available.

41.

Down-regulation of beta-catenin by activated p53.

Sadot E, Geiger B, Oren M, Ben-Ze'ev A.

Mol Cell Biol. 2001 Oct;21(20):6768-81.

42.

Deregulated beta-catenin induces a p53- and ARF-dependent growth arrest and cooperates with Ras in transformation.

Damalas A, Kahan S, Shtutman M, Ben-Ze'ev A, Oren M.

EMBO J. 2001 Sep 3;20(17):4912-22.

43.

De novo formation of focal complex-like structures in host cells by invading Streptococci.

Ozeri V, Rosenshine I, Ben-Ze'Ev A, Bokoch GM, Jou TS, Hanski E.

Mol Microbiol. 2001 Aug;41(3):561-73.

44.

Reduced expression of plakoglobin correlates with adverse outcome in patients with neuroblastoma.

Amitay R, Nass D, Meitar D, Goldberg I, Davidson B, Trakhtenbrot L, Brok-Simoni F, Ben-Ze'ev A, Rechavi G, Kaufmann Y.

Am J Pathol. 2001 Jul;159(1):43-9.

45.

Cadherin sequences that inhibit beta-catenin signaling: a study in yeast and mammalian cells.

Simcha I, Kirkpatrick C, Sadot E, Shtutman M, Polevoy G, Geiger B, Peifer M, Ben-Ze'ev A.

Mol Biol Cell. 2001 Apr;12(4):1177-88.

46.

Recruitment of beta-catenin to cadherin-mediated intercellular adhesions is involved in myogenic induction.

Goichberg P, Shtutman M, Ben-Ze'ev A, Geiger B.

J Cell Sci. 2001 Apr;114(Pt 7):1309-19.

47.

The integration of cell adhesion with gene expression: the role of beta-catenin.

Ben-Ze'ev A, Shtutman M, Zhurinsky J.

Exp Cell Res. 2000 Nov 25;261(1):75-82. Review. No abstract available.

PMID:
11082277
48.

Plakoglobin and beta-catenin: protein interactions, regulation and biological roles.

Zhurinsky J, Shtutman M, Ben-Ze'ev A.

J Cell Sci. 2000 Sep;113 ( Pt 18):3127-39. Review.

49.

The integrin-linked kinase regulates the cyclin D1 gene through glycogen synthase kinase 3beta and cAMP-responsive element-binding protein-dependent pathways.

D'Amico M, Hulit J, Amanatullah DF, Zafonte BT, Albanese C, Bouzahzah B, Fu M, Augenlicht LH, Donehower LA, Takemaru K, Moon RT, Davis R, Lisanti MP, Shtutman M, Zhurinsky J, Ben-Ze'ev A, Troussard AA, Dedhar S, Pestell RG.

J Biol Chem. 2000 Oct 20;275(42):32649-57.

50.

Supplemental Content

Loading ...
Support Center